Pfizer faces DOJ, SEC foreign bribery probes for China, Russia operationsnews2020-11-09T14:55:13+00:00November 9th, 2020|Fierce Pharma|
Ironwood names proxy brawler Denner to its board a year after R&D spinoffnews2020-11-09T14:51:33+00:00November 9th, 2020|Fierce Pharma|
Fierce Pharma Politics—Biden puts COVID-19 transition task force on the jobnews2020-11-09T14:15:44+00:00November 9th, 2020|Fierce Pharma|
GlaxoSmithKline’s HIV PrEP challenge looms as ViiV’s long-acting drug tops Gilead’s Truvada in womennews2020-11-09T12:58:26+00:00November 9th, 2020|Fierce Pharma|
Novo Nordisk lays out $1.8B for Emisphere and its oral delivery technews2020-11-06T16:12:20+00:00November 6th, 2020|Fierce Pharma|
Eli Lilly bids farewell to longtime digital chief Shahnews2020-11-06T15:50:50+00:00November 6th, 2020|Fierce Pharma|
AstraZeneca’s Brilinta won its coveted stroke-prevention nod. Will it be enough to boost long-term sales?news2020-11-06T14:45:56+00:00November 6th, 2020|Fierce Pharma|
Regeneron predicts 300,000 COVID-19 cocktail doses ready by January, and ‘substantially more’ in 2021news2020-11-06T14:26:45+00:00November 6th, 2020|Fierce Pharma|
FiercePharmaAsia—AstraZeneca’s China slowdown; Novartis’ Asia CAR-T site; Clover’s COVID-19 fundingnews2020-11-06T12:45:12+00:00November 6th, 2020|Fierce Pharma|
Shrimp-shell nanoparticle could cut cancer drug side effects and improve durability, mouse study showsnews2020-11-05T16:53:32+00:00November 5th, 2020|Fierce Pharma|
